Oral Antibiotic Bowel Preparation in Gynecologic Oncology Surgery

WellSpan Health

Status: Completed

Conditions: Surgical Site Infection; Gynecologic Cancer; Surgical Complication

Treatments: Other: Diagnosed with Surgical Site Infection

Study type: Observational

Funder types: Other

Identifiers

NCT05210556

1847220-1

Details and patient eligibility

About

The purpose of this study is to investigate whether the use of a preoperative antibiotic bowel regimen is associated with a reduced risk of deep organ/space surgical site infection in gynecologic oncology surgery.

Full description

This is a retrospective chart review study. Patients who underwent scheduled intra-abdominal surgery with a WellSpan gynecologic oncologist will be identified and their chart reviewed for demographic data of age, race, BMI, comorbidities, and type of surgery. Those patients who had a deep organ/space surgical site infection within 30 days postoperatively will be identified. The numbers of these infections before and after August 2020, at which time all patients moving forwards were prescribed antibiotic bowel preparation, will then be statistically analyzed and compared to see if the institution of the antibiotic bowel preparation was associated with a reduction in surgical site infection.

Enrollment: 778 patients

Sex: Female

Ages: 18 to 99 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Underwent scheduled intra-abdominal surgery with a WellSpan gynecologic oncologist

Exclusion criteria

• Unscheduled surgery
• Intraoperative consult by a WellSpan gynecologic oncologist

Trial design

778 participants in 2 patient groups

No Antibiotic Bowel Prep

Description:

Patients who did not receive a preoperative antibiotic bowel preparation

Treatment:

Other: Diagnosed with Surgical Site Infection

Antibiotic Bowel Prep

Description:

Patients who did receive a preoperative antibiotic bowel preparation